Literature DB >> 24116703

Emerging role of interleukin-33 in autoimmune diseases.

Cheng Pei1, Mark Barbour, Karen J Fairlie-Clarke, Debbie Allan, Rong Mu, Hui-Rong Jiang.   

Abstract

Interleukin-33 (IL-33) is a member of the IL-1 cytokine family. It predominantly induces type 2 immune responses and thus is protective against atherosclerosis and nematode infections but contributes to allergic airway inflammation. Interleukin-33 also plays a pivotal role in the development of many autoimmune diseases through mechanisms that are still not fully understood. In this review, we focus on the recent advances in understanding of the expression and function of IL-33 in some autoimmune disorders, aiming to provide insight into its potential role in disease development.
© 2013 John Wiley & Sons Ltd.

Entities:  

Keywords:  ST2; autoimmune diseases; inflammation; interleukin-33

Mesh:

Substances:

Year:  2014        PMID: 24116703      PMCID: PMC3893845          DOI: 10.1111/imm.12174

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  95 in total

Review 1.  Inflammatory bowel disease: cause and immunobiology.

Authors:  Daniel C Baumgart; Simon R Carding
Journal:  Lancet       Date:  2007-05-12       Impact factor: 79.321

2.  Epithelial-derived IL-33 and its receptor ST2 are dysregulated in ulcerative colitis and in experimental Th1/Th2 driven enteritis.

Authors:  Luca Pastorelli; Rekha R Garg; Sharon B Hoang; Luisa Spina; Benedetta Mattioli; Melania Scarpa; Claudio Fiocchi; Maurizio Vecchi; Theresa T Pizarro
Journal:  Proc Natl Acad Sci U S A       Date:  2010-04-12       Impact factor: 11.205

3.  Serum levels of IL-33 and soluble ST2 and their association with disease activity in systemic lupus erythematosus.

Authors:  Mo Yin Mok; Fang Ping Huang; Wai Ki Ip; Yi Lo; Fung Yi Wong; Eric Yuk Tat Chan; Kwok Fai Lam; Damo Xu
Journal:  Rheumatology (Oxford)       Date:  2009-12-21       Impact factor: 7.580

4.  Association of increased serum IL-33 levels with clinical and laboratory characteristics of systemic lupus erythematosus in Chinese population.

Authors:  Zaixing Yang; Yan Liang; Weiqiang Xi; Chang Li; Renqian Zhong
Journal:  Clin Exp Med       Date:  2010-10-21       Impact factor: 3.984

5.  IL-1 receptor accessory protein is essential for IL-33-induced activation of T lymphocytes and mast cells.

Authors:  Shafaqat Ali; Michael Huber; Christian Kollewe; Stephan C Bischoff; Werner Falk; Michael U Martin
Journal:  Proc Natl Acad Sci U S A       Date:  2007-11-14       Impact factor: 11.205

6.  Serum IL-33 levels and skin mRNA expression in Behçet's disease.

Authors:  Kamel Hamzaoui; Wajih Kaabachi; Bessima Fazaa; Leith Zakraoui; Ilhem Mili-Boussen; Faycal Haj-Sassi
Journal:  Clin Exp Rheumatol       Date:  2013-03-04       Impact factor: 4.473

7.  Inhibition of interleukin-33 signaling attenuates the severity of experimental arthritis.

Authors:  Gaby Palmer; Dominique Talabot-Ayer; Céline Lamacchia; Dean Toy; Christian A Seemayer; Sébastien Viatte; Axel Finckh; Dirk E Smith; Cem Gabay
Journal:  Arthritis Rheum       Date:  2009-03

8.  The ST2 pathway is involved in acute pancreatitis: a translational study in humans and mice.

Authors:  Romy Ouziel; Thierry Gustot; Christophe Moreno; Marianna Arvanitakis; Delphine Degré; Eric Trépo; Eric Quertinmont; Vincent Vercruysse; Pieter Demetter; Olivier Le Moine; Andrew N J McKenzie; Myriam Delhaye; Jacques Devière; Arnaud Lemmers
Journal:  Am J Pathol       Date:  2012-04-24       Impact factor: 4.307

9.  IL-33 induces innate lymphoid cell-mediated airway inflammation by activating mammalian target of rapamycin.

Authors:  Robert J Salmond; Ananda S Mirchandani; Anne-Gaelle Besnard; Calum C Bain; Neil C Thomson; Foo Y Liew
Journal:  J Allergy Clin Immunol       Date:  2012-06-26       Impact factor: 10.793

10.  Emerging role of the interleukin (IL)-33/ST2 axis in gut mucosal wound healing and fibrosis.

Authors:  Loris R Lopetuso; Franco Scaldaferri; Theresa T Pizarro
Journal:  Fibrogenesis Tissue Repair       Date:  2012-10-14
View more
  36 in total

1.  IL-33 Signaling Protects from Murine Oxazolone Colitis by Supporting Intestinal Epithelial Function.

Authors:  Amanda Waddell; Jefferson E Vallance; Preston D Moore; Amy T Hummel; David Wu; Shiva K Shanmukhappa; Lin Fei; M Kay Washington; Phillip Minar; Lori A Coburn; Susumu Nakae; Keith T Wilson; Lee A Denson; Simon P Hogan; Michael J Rosen
Journal:  Inflamm Bowel Dis       Date:  2015-12       Impact factor: 5.325

2.  Prolonged activation of IL-5-producing ILC2 causes pulmonary arterial hypertrophy.

Authors:  Masashi Ikutani; Koichi Tsuneyama; Makoto Kawaguchi; Junya Fukuoka; Fujimi Kudo; Susumu Nakae; Makoto Arita; Yoshinori Nagai; Satoshi Takaki; Kiyoshi Takatsu
Journal:  JCI Insight       Date:  2017-04-06

3.  Alzheimer's disease: evidence for the expression of interleukin-33 and its receptor ST2 in the brain.

Authors:  Zhi Xiong; Ramasamy Thangavel; Duraisamy Kempuraj; Evert Yang; Smita Zaheer; Asgar Zaheer
Journal:  J Alzheimers Dis       Date:  2014       Impact factor: 4.472

4.  The full-length interleukin-33 (FLIL33)-importin-5 interaction does not regulate nuclear localization of FLIL33 but controls its intracellular degradation.

Authors:  Andrew Clerman; Zahid Noor; Rita Fishelevich; Virginia Lockatell; Brian S Hampton; Nirav G Shah; Mariah V Salcedo; Nevins W Todd; Sergei P Atamas; Irina G Luzina
Journal:  J Biol Chem       Date:  2017-11-10       Impact factor: 5.157

5.  Interleukin-33 predicts poor prognosis and promotes ovarian cancer cell growth and metastasis through regulating ERK and JNK signaling pathways.

Authors:  Xiaoguang Tong; Mark Barbour; Kezuo Hou; Chao Gao; Shuang Cao; Jingli Zheng; Yang Zhao; Rong Mu; Hui-Rong Jiang
Journal:  Mol Oncol       Date:  2015-09-09       Impact factor: 6.603

6.  Glia maturation factor deficiency suppresses 1-methyl-4-phenylpyridinium-induced oxidative stress in astrocytes.

Authors:  Mohammad Moshahid Khan; Duraisamy Kempuraj; Smita Zaheer; Asgar Zaheer
Journal:  J Mol Neurosci       Date:  2014-01-16       Impact factor: 3.444

Review 7.  Role of the Immune System in Hypertension.

Authors:  Bernardo Rodriguez-Iturbe; Hector Pons; Richard J Johnson
Journal:  Physiol Rev       Date:  2017-07-01       Impact factor: 37.312

8.  Activated mast cells synthesize and release soluble ST2-a decoy receptor for IL-33.

Authors:  Geethani Bandara; Michael A Beaven; Ana Olivera; Alasdair M Gilfillan; Dean D Metcalfe
Journal:  Eur J Immunol       Date:  2015-09-09       Impact factor: 5.532

9.  Chronic stress, cortisol dysfunction, and pain: a psychoneuroendocrine rationale for stress management in pain rehabilitation.

Authors:  Kara E Hannibal; Mark D Bishop
Journal:  Phys Ther       Date:  2014-07-17

Review 10.  Caspase-1: an integral regulator of innate immunity.

Authors:  Stefan Winkler; Angela Rösen-Wolff
Journal:  Semin Immunopathol       Date:  2015-06-10       Impact factor: 9.623

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.